ML-193 (CID 1261822) is a potent and selective GPR55 antagonist (IC50: 221 nM) with over 27-fold selectivity for GPR55 over GPR35, CB1, and CB2. It can ameliorate motor and sensorimotor deficits in Parkinsons disease (PD) rats.
Molecular Weight:
527.59
Purity:
99.79%
CAS Number:
[713121-80-3]
Formula:
C28H25N5O4S
Target:
Cannabinoid Receptor
T22103
* VAT and and shipping costs not included. Errors and price changes excepted